Clinical Trial Update: A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of palbociclib (PD-0332991) in advanced hepatocellular carcinoma has completed with results posted (2018-01-05).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Advanced Hepatocellular Carcinoma, HCC | Phase 2 | Status: COMPLETED | Results posted: 2018-01-05